MTOR and breast carcinoma: Analysis of a public database of breast cancer samples identified decreased SIRT1 mRNA levels, increased mTOR and Skp2 mRNA levels in 31 breast cancer cell samples with a BRCA1 mutation, compared with 128 breast cancer cell samples without BRCA1 mutation (Fig. 2C and Supplementary Fig. S1)19.